Entertainment

Leading Development of New International Standard, WeBank Efforts to Promote Trusted Personal Data Circulation

SHENZHEN,China,Nov. 12,2024-- International standards organization Institute of Electrical and Electronics Engineers Standards Association (IEEESA) has recently announced the approval of the developme

11-13 WeBank Co. Ltd.

Fliggy Reports Strong Growth as 22 Top Brands Surpass RMB100 Million in Sales During Double 11

Platform drives significant rise in transactions and expands user base amid challenging market conditions

11-13 fliggy

Tencent Music Entertainment Group Announces Third Quarter 2024 Unaudited Financial Results

SHENZHEN,China,Nov. 12,2024-- Tencent Music Entertainment Group ("TME," or the "Company") (NYSE: TME and HKEX: 1698),the leading online music and audio entertainment platform in Ch

11-13 Tencent Music Entertainment Group

X2O Media Installs Cutting-Edge Hybrid Classroom at Leading UK Independent School

MONTRÉAL,Nov. 12,2024-- X2O Media,a global provider of hybrid learning and training solutions,today announced the installation of X2O OneRoom classroom at Repton School in Derbyshire,England.

11-13 X2O Media Inc.

FACTORY DEMAND WEAKENS ACROSS MAJOR ECONOMIES IN OCTOBER: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

U.S. factories cut back purchases sharply,signaling heightened risks of manufacturing weakness spilling over into the broader economy in 2025

11-13 GEP

Global Vloggers Explore China Huadian's Landmark Energy Projects

DENPASAR,Indonesia,Nov. 12,2024-- A group of internationalvloggers has embarked on a journey to document China Huadian Corporation\'s overseas projects along the Belt and Road Initiative,showcasing th

11-13 China Huadian Corporation Ltd.

Ascletis Completes Enrollment of Phase III Trial of ASC40 (Denifanstat) Once-Daily Oral Tablet for Treatment of Acne

-Phase III trial enrolled a total of 480 patients with moderate to severe acne -Topline results expected in the second quarter 2025

11-13 Ascletis Pharma Inc.

Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy Participants, Demonstrating 4.16% Weight Reduction in Two Weeks

After two weeks of treatment,GZR18 tablets resulted in an average weight reduction of up to 4.16%,with continued weight loss observed even after discontinuation.

11-13 Gan & Lee Pharmaceuticals

YCH Group Partners with Vietnamese Government to Propel SMEs onto the Global Stage

SINGAPORE,Nov. 13,2024-- In a significant move to strengthen Vietnam\'s presence in international markets,the country\'s Minister of Information and Communications,Nguyen Manh Hung,has invited Singap

11-13 YCH Group

Xiao-I Corporation Enhances HR Operations for Hong Kong Public Sector Client with AI-Powered Solution, Generating Initial Revenue of 8 Million HKD

SHANGHAI,Nov. 11,2024-- Xiao-I Corporation (NASDAQ: AIXI),a leading AI enterprise,today announced a strategic agreement with an undisclosed Hong Kong public sector client. This engagement further soli

11-12 Xiao I Corporation